Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Smartphone apps and wearables could transform heart recovery

NCT ID NCT07741396

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Aug 03, 2026 · Last updated Aug 04, 2026 · Updated 1 time

Summary

This study tests whether adding mobile health tools—like smartphone apps, connected scales, blood pressure monitors, and activity trackers—to standard cardiac rehab helps heart patients monitor their health and stick to healthy habits at home. The trial enrolls adults who have had a heart attack, heart surgery, or other qualifying heart conditions and are referred to a center-based rehab program. Participants will use these tools alongside their usual rehab sessions to see if it improves their fitness, blood pressure, and overall well-being.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
A mobile health intervention combining smartphone apps, connected devices (scale, blood pressure monitor, activity tracker), and personalized text messages, added to standard center-based cardiac rehabilitation.
What this could lead to
If effective, this approach could make cardiac rehab more engaging and help heart patients sustain healthy habits at home, potentially improving long-term outcomes.
What could go wrong
This is a small pilot study (30 participants), so results may not apply broadly. The mobile tools might not significantly improve outcomes, and some patients may find them difficult to use.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 30 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Sep 2026

An estimate. Start dates often move.

Expected to finish

Jul 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: 1. Adults aged 18 years or older. 2. Enrolled in or referred to Phase II Center-based Cardiac Rehabilitation Program. 3. Have a qualifying cardiovascular diagnosis or event that meets standard eligibility for Phase II Center-based Cardiac Rehabilitation, such as: * Acute myocardial infarction * Percutaneous coronary intervention * Coronary artery bypass graft surgery * Chronic heart failure with reduced ejection fraction * Heart valve repair or replacement * Stable angina 4. Able to ambulate and participate in exercise testing and training as required by the CR program 5. Ability to speak and read in English 6. Willing and able to provide informed consent. 7. Willing to use study-related devices/apps and complete study assessments. Exclusion Criteria: 1. Not enrolled in or not planning to participate in Phase II Center-based Cardiac Rehabilitation Program. 2. Presence of a medical, cognitive, psychiatric, or physical condition that, in the opinion of the investigators or CR team, would preclude safe participation in the study or adherence to study procedures. 3. Severe cognitive impairment or active psychiatric illness that would interfere with informed consent or study participation. 4. Terminal illness or other serious medical condition that in the judgement of the treating clinician or investigator would likely preclude completion of the study follow-up period. . 5. Current hospice enrollment or residence in a long-term care facility that would preclude participation in the intervention or completion of study follow-up procedures. 6. Currently participating in another behavioral or digital health intervention trial that could confound study outcomes. 7. Inability or unwillingness to use the required mobile devices, applications, or monitoring equipment, if applicable.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Acute myocardial infarction (AMI) are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  2. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

More trials for these conditions

Other studies related to the condition(s) this trial covers.